Llaguno-Munive, M., León-Zetina, S., Vazquez-Lopez, I., Ramos-Godinez, M. d. P., Medina, L. A., & Garcia-Lopez, P. (2020). Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide. Front Oncol.

Llaguno-Munive, Monserrat, Sebastián León-Zetina, Inés Vazquez-Lopez, María del Pilar Ramos-Godinez, Luis A. Medina, and Patricia Garcia-Lopez. "Mifepristone As a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide." Front Oncol 2020.

Llaguno-Munive, Monserrat, et al. "Mifepristone As a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide." Front Oncol 2020.